JPRN-UMIN000008874
Completed
未知
Feasibility study of photodynamic diagnosis using 5ALA for early head and neck or gastrointestinal cancer - Feasibility study of 5ALA-PDD
ational Cancer Center Hospital East0 sites8 target enrollmentSeptember 7, 2012
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- early head and neck or gastrointestinal cancer
- Sponsor
- ational Cancer Center Hospital East
- Enrollment
- 8
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) A history of photosensitivity. 2\) Porphyria. 3\) Women during pregnancy or breast\-feeding. 4\) Cirrhosis, acute or chronic hepatitis. 5\) Systemic treatment is indicated for bacterial or fungal infection. 6\) Positive HBs antigen, HCV antibody or known positive serology for HIV. 7\) Patient is judged to be inappropriate for study participation for any reason by the investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Feasibility study of photodynamic diagnosis using 5-aminolaevulinic acid during endoscopic submucosal dissection for early gastric cancerEarly gastric cancerJPRN-UMIN000027996Kochi Medical School2
Completed
Phase 1
Feasibility study of in vivo photodynamic diagnosis using 5ALA for head and neck or gastrointestinal cancerHead and neck or Gastrointestinal cancerJPRN-UMIN000013791ational Cancer Center Hospital East16
Completed
Not Applicable
Pilot study of photodynamic diagnosis with 5 aminolevulinic acid for Esophageal Cancer.JPRN-UMIN000032209Tokyo Women's Medical Universty30
Completed
Phase 3
The efficacy and safety of photodynamic diagnosis with SPP-005 at staging laparoscopy for advanced gastric cancer. Prospective multi-center trial.large type 3 or type 4 gastric cancerJPRN-jRCT2091220309Osaka University Hospital105
Completed
Phase 1
The safety and efficacy of photodynamic diagnosis with SPP-006 at staging laparoscopy for advanced gastric cancer. Prospective multi-center trial.JPRN-jRCT2091220225Osaka University Hospital30